Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
An announcement from MicroPort Scientific ( (HK:0853) ) is now available.
Shanghai MicroPort Endovascular MedTech (Group) Co., Ltd., a subsidiary of MicroPort Scientific, reported a decline in revenue and profit for the first half of 2025 compared to the same period in 2024. Despite a decrease in financial performance, the company’s total assets and equity showed growth, indicating a mixed impact on its operations and potential implications for stakeholders.
The most recent analyst rating on (HK:0853) stock is a Buy with a HK$17.20 price target. To see the full list of analyst forecasts on MicroPort Scientific stock, see the HK:0853 Stock Forecast page.
More about MicroPort Scientific
MicroPort Scientific is a company engaged in the medical technology industry, focusing on the development and manufacturing of medical devices. Its primary products and services include endovascular and cardiovascular medical technologies, with a market focus on innovative solutions for healthcare.
Average Trading Volume: 44,398,062
Technical Sentiment Signal: Buy
Current Market Cap: HK$23.95B
For a thorough assessment of 0853 stock, go to TipRanks’ Stock Analysis page.